Share
Market Research Report

GASTROPARESIS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassProkinetic Agents · Antiemetic Drugs · Proton Pump Inhibitors · Others
  • By Disease IndicationDiabetes Gastroparesis · Idiopathic Gastroparesis · Post-surgical Gastroparesis
  • By TypeOver-the-Counter Drugs and Prescription Drugs
  • By Route of AdministrationOral · Injectables · Nasal
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · Online Pharmacies
  • By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
  • Published In03 Apr 2026
  • Report CodeCMI5123
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Gastroparesis Treatment Market, By Drug Class
      • Global Gastroparesis Treatment Market, By Disease Indication
      • Global Gastroparesis Treatment Market, By Type
      • Global Gastroparesis Treatment Market, By Route of Administration
      • Global Gastroparesis Treatment Market, By Distribution Channel
      • Global Gastroparesis Treatment Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Gastroparesis Treatment Market, By Drug Class, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Prokinetic Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Antiemetic Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Proton Pump Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (Botulinum Toxin Injections, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Gastroparesis Treatment Market, By Disease Indication, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Diabetes Gastroparesis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Idiopathic Gastroparesis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Post-surgical Gastroparesis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Gastroparesis Treatment Market, By Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Over-the-Counter Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Prescription Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Gastroparesis Treatment Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Injectables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Nasal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Gastroparesis Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Gastroparesis Treatment Market, By Region, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022- 2033, e (USD Bn)
      • Regional Trends
    • North America

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Disease Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Disease Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Disease Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Disease Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Disease Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa

      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Disease Indication, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country/Sub-region, 2021 - 2033, (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  10. Competitive Landscape

    • Evoke Pharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Processa Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Neurogastrx, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Vanda Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ANI Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Otsuka Holdings Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CinDome Pharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • PTC Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Atlantic Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Salix Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Rhythm Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ironwood Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bausch Health Companies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Gastroparesis Treatment Market' - Global forecast to 2033